Cell Signaling Technology

PhosphoPlus® LKB1 (Ser428) Antibody Duet

#5132 · $673

100
Citing papers
10k
Combined citations
Supplier page Find this product

Research areas

Autophagy in Disease and Therapy7Adipose Tissue and Metabolism6Cancer Immunotherapy and Biomarkers5Cancer-related gene regulation5Adipokines, Inflammation, and Metabolic Diseases5Cancer Cells and Metastasis5RNA modifications and cancer5Wnt/β-catenin signaling in development and cancer5

Papers citing this product

1
Tissue Distribution of 5-Hydroxymethylcytosine and Search for Active Demethylation Intermediates
PLoS ONE·2010·856 cit.·DOI
2
Distinct requirements for Ras oncogenesis in human versus mouse cells
Genes & Development·2002·422 cit.·DOI
3
c-Myc Is Required for Maintenance of Glioma Cancer Stem Cells
PLoS ONE·2008·422 cit.·DOI
4
Implications of the tumor immune microenvironment for staging and therapeutics
Modern Pathology·2017·364 cit.·DOI
5
SIRT4 Is a Lysine Deacylase that Controls Leucine Metabolism and Insulin Secretion
Cell Metabolism·2017·322 cit.·DOI
6
Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF‐κB and AP‐1 activation and IL‐8 and VEGF expression in human head and neck squamous cell carcinoma lines
International Journal of Cancer·2002·231 cit.·DOI
7
Differentiation of Human Circulating Fibrocytes as Mediated by Transforming Growth Factor-β and Peroxisome Proliferator-activated Receptor γ
Journal of Biological Chemistry·2007·225 cit.·DOI
8
The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion
PLoS ONE·2012·223 cit.·DOI
9
Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis
Nature Communications·2015·199 cit.·DOI
10
Phosphoinositide-3 Kinase-Akt Pathway Controls Cellular Entry of Ebola Virus
PLoS Pathogens·2008·197 cit.·DOI
PhosphoPlus® LKB1 (Ser428) Antibody Duet — Evidence — PubIndex